A carregar...

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial

Results from the completed treatment analysis of the ATAC (Arimidex, Tamoxifen alone or in combination) trial indicated that anastrozole was significantly superior to tamoxifen in terms of efficacy and safety in the adjuvant treatment of postmenopausal women with hormone receptor-positive (HR+) earl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mansel, R, Locker, G, Fallowfield, L, Benedict, Á, Jones, D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360294/
https://ncbi.nlm.nih.gov/pubmed/17622238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603804
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!